Exercise-induced change in circulating NT-proBNP could not distinguish between patients with and without coronary

Joanna Cwikiel1,2,3, Morten W Fagerland4, Kristian Wachtell5

  • 1Center for Clinical Heart Research, Department of Cardiology, Oslo University Hospital Ullevaal, Oslo, Norway.

Insights

Resting NT-proBNP levels were higher in patients with coronary artery disease (CAD). Combining resting NT-proBNP with exercise stress tests improved CAD prediction compared to exercise tests alone.

Area of Science:

  • Cardiology
  • Biomarkers
  • Diagnostic Accuracy

Background:

  • Exercise stress tests have moderate accuracy for diagnosing coronary artery disease (CAD).
  • Cardiac biomarkers could enhance the diagnostic precision of exercise stress testing.
  • N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a potential biomarker for cardiovascular conditions.

Purpose of the Study:

  • To investigate circulating NT-proBNP levels before and during exercise stress tests in patients with and without CAD.
  • To determine if NT-proBNP provides additive diagnostic value to exercise stress tests for CAD.
  • To compare NT-proBNP levels in patients with and without angiographically verified CAD.

Main Methods:

  • Recruited 297 patients with stable CAD symptoms undergoing maximal bicycle ergometer stress tests.
  • Collected venous blood samples at rest and within 5 minutes post-exercise for NT-proBNP measurement.
  • Performed coronary angiography to define significant CAD (≥75% stenosis).

Main Results:

  • Significant CAD was identified in 111 (37%) participants.
  • Resting NT-proBNP levels were significantly higher in patients with CAD (74.18 ng/L) versus without CAD (56.03 ng/L).
  • Exercise-induced NT-proBNP increase did not differ significantly between groups; however, combining resting NT-proBNP with a positive stress test improved CAD prediction (AUC=0.68 vs 0.64).

Conclusions:

  • Exercise-induced changes in NT-proBNP do not differentiate between patients with or without CAD.
  • Resting NT-proBNP levels are significantly elevated in patients with CAD.
  • Resting NT-proBNP may offer additive value when combined with exercise stress testing for CAD diagnosis.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
230
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
27
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
359
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
58
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
90
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
79